TCR2 Therapeutics Inc. (TCRR) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 BINNEY STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments149,179,000265,593,000227,986,000158,124,000
Cash and cash equivalents32,746,000222,564,00094,155,00065,296,000
Short-term investments116,433,00043,029,000133,831,00092,828,000
Other undisclosed current assets28,442,00010,534,0007,552,0005,061,000
Total current assets:177,621,000276,127,000235,538,000163,185,000
Noncurrent Assets
Operating lease, right-of-use asset22,510,00028,283,000  
Property, plant and equipment6,166,00017,075,00010,013,0004,926,000
Restricted cash and investments1,152,0001,156,000583,000417,000
Deferred costs   61,000 
Other noncurrent assets787,000730,000  
Total noncurrent assets:30,615,00047,244,00010,657,0005,343,000
TOTAL ASSETS:208,236,000323,371,000246,195,000168,528,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13,616,00015,238,0008,840,0007,533,000
Accounts payable2,793,0002,144,0002,448,0002,483,000
Accrued liabilities10,823,00013,094,0006,392,0005,050,000
Other undisclosed current liabilities50,445,0003,367,000  
Total current liabilities:64,061,00018,605,0008,840,0007,533,000
Noncurrent Liabilities
Long-term debt and lease obligation:  22,996,000  
Liabilities, other than long-term debt3,316,000293,000807,000546,000
Other liabilities  293,000807,000546,000
Operating lease, liability3,316,00022,996,000  
Total noncurrent liabilities:3,316,00023,289,000807,000546,000
Total liabilities:67,377,00041,894,0009,647,0008,079,000
Equity
Equity, attributable to parent140,859,000281,477,000236,548,000160,449,000
Common stock4,0004,0003,0002,000
Additional paid in capital642,644,000631,008,000486,197,000342,896,000
Accumulated other comprehensive income (loss)(445,000)(13,000)63,000142,000
Accumulated deficit(501,344,000)(349,522,000)(249,715,000)(182,591,000)
Total equity:140,859,000281,477,000236,548,000160,449,000
TOTAL LIABILITIES AND EQUITY:208,236,000323,371,000246,195,000168,528,000

Income Statement (P&L) (USD)

3/31/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating expenses(153,499,000)(99,742,000)(68,700,000)(51,382,000)
Operating loss:(153,499,000)(99,742,000)(68,700,000)(51,382,000)
Nonoperating income1,938,000224,0001,737,0003,885,000
Loss from continuing operations before income taxes:(151,561,000)(99,518,000)(66,963,000)(47,497,000)
Income tax expense(261,000)(289,000)(161,000)(102,000)
Loss from continuing operations:(151,822,000)(99,807,000)(67,124,000)(47,599,000)
Loss before gain (loss) on sale of properties:(99,807,000)(67,124,000)(47,599,000)
Net loss attributable to parent:(151,822,000)(99,807,000)(67,124,000)(47,599,000)
Preferred stock dividends and other adjustments    (49,900,000)
Net loss available to common stockholders, diluted:(151,822,000)(99,807,000)(67,124,000)(97,499,000)

Comprehensive Income (USD)

3/31/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(151,822,000)(99,807,000)(67,124,000)(47,599,000)
Comprehensive loss:(151,822,000)(99,807,000)(67,124,000)(47,599,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(432,000)(76,000)(79,000)248,000
Comprehensive loss, net of tax, attributable to parent:(152,254,000)(99,883,000)(67,203,000)(47,351,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: